Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
16.18
-0.57 (-3.40%)
Dec 3, 2024, 12:49 PM EST - Market open
Assembly Biosciences Revenue
Assembly Biosciences had revenue of $6.85M in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $28.33M. In the year 2023, Assembly Biosciences had annual revenue of $7.16M.
Revenue (ttm)
$28.33M
Revenue Growth
n/a
P/S Ratio
3.37
Revenue / Employee
$435,785
Employees
65
Market Cap
102.84M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Quipt Home Medical | 244.23M |
Karyopharm Therapeutics | 148.44M |
FONAR | 102.01M |
Akoya Biosciences | 86.82M |
Veru Inc. | 14.09M |
Coya Therapeutics | 9.55M |
INmune Bio | 42.00K |
ASMB News
- 5 months ago - Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inhibitors at International Herpesvirus Workshop - GlobeNewsWire
- 6 months ago - Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus Helicase-Primase Inhibitor Candidate ABI-5366 - GlobeNewsWire
- 6 months ago - Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congress™ 2024 - GlobeNewsWire
- 7 months ago - Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights - GlobeNewsWire
- 8 months ago - Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights - GlobeNewsWire
- 10 months ago - Assembly Biosciences Announces Effective Date of Reverse Stock Split - GlobeNewsWire
- 11 months ago - Assembly Biosciences Provides Anticipated Development Milestones for 2024 - GlobeNewsWire
- 1 year ago - Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire